Skip to main content
See every side of every news story
Published loading...Updated

HRV Pharma invests ₹150 crore to boost peptide, oncology API capacity

Summary by Times of India
HRV Pharma to invest ₹150 crore to expand synthetic peptide and high-potency oncology API capacity via partner facilities, targeting US/EU markets and complex drugs.

Bias Distribution

  • 100% of the sources lean Right
100% Right

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Times of India broke the news in India on Monday, September 7, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal